IVFH - i completely agree with you, SSK, on the fundies and technicals, EPS-estimates, and price-targets. Thanks for the clarity on those extra shares generated by the conversions. It was clear to me for months that a paper overhang was slowly being worked through, hence the shareprice weakness over these months.
But i'm not selling. One never knows when this could re-set higher, much higher, on the current "outrageous undervaluation."
I had a brief exchange with shareholder Dickmo over at the IVFH board here at Ihub. (He's been a tough critic of the CEO over the quarters.) He doesn't think this OTC-listed, CEO-disliked company so reliant on a single customer deserves any kind of growth P/E.....
But i figure if the company could just get a P/E of 11-12 in the weeks subsequent to their FY report next March, by which time they should have a trailing EPS of AT LEAST 0.14-0.15 (if not hitting your growth estimate of .17-.20 EPS for 2017), then we're talking about a stockprice of somewhere around $1.60-$1.80, if not well over $2.
News 
Market Data 
Discover 
